S. Apraş

发表

Intensified, intermittent, low-dose intravenous cyclophosphamide together with oral alternate-day steroid therapy in lupus nephritis (long-term outcome)

S. Kiraz, M. Calguneri, Z. Ozbalkan, 2006, Clinical Rheumatology.

Evaluation of vascular injury with proinflammatory cytokines, thrombomodulin and fibronectin in patients with primary fibromyalgia.

S. Pay, A. Dinç, S. Kiraz, 2000, Nagoya journal of medical science.

The efficacy of oral cyclophosphamide plus prednisolone in early diffuse systemic sclerosis

S. Kiraz, I. Ertenli, M. Calguneri, 2003, Clinical Rheumatology.

Effects of oral cyclophosphamide and prednisolone therapy on the endothelial functions and clinical findings in patients with early diffuse systemic sclerosis.

I. Haznedaroglu, S. Pay, S. Kiraz, 2003, Arthritis and rheumatism.

Successful treatment of rheumatoid arthritis is associated with a reduction in serum sE-selectin and thrombomodulin level

I. Haznedaroglu, S. Kiraz, I. Ertenli, 2004, Clinical Rheumatology.

The efficacy of continuous interferon alpha administration as an adjunctive agent to colchicine-resistant familial Mediterranean fever patients.

S. Kiraz, I. Ertenli, M. Calguneri, 2004, Clinical and experimental rheumatology.

Wegener's granulomatosis: clinical and laboratory results of a university hospital study of 20 patients from Turkey

S. Kiraz, M. Calguneri, Z. Ozbalkan, 2006, Clinical Rheumatology.

Clinical significance of hemostatic markers and thrombomodulin in systemic lupus erythematosus: evidence for a prothrombotic state

S. Kiraz, I. Ertenli, M. Calguneri, 1999, Lupus.

Neutrophil CD64 expression in Behçet's disease.

A. Akdoğan, S. Kiraz, I. Ertenli, 2005, The Journal of rheumatology.

Plasma Thrombopoietin in Patients With Cavernous Transformation of the Portal Vein

Y. Bayraktar, N. Sayınalp, Ş. Kirazlı, 2002, International journal of hematology.

No Evidence of Cardiac Autonomic Involvement in Ankylosing Spondylitis, as Assessed by Heart Rate Variability

A. Oto, K. Aytemir, A. Yıldırır, 2001, Clinical Rheumatology.

Effects of interferon α treatment on the clinical course of refractory Behçet’s disease: an open study

S. Kiraz, I. Ertenli, M. Calguneri, 2003, Annals of the rheumatic diseases.

The efficacy of interferon-alpha in a patient with resistant familial Mediterranean fever complicated by polyarteritis nodosa.

M. Calguneri, Z. Ozbalkan, M. Ozturk, 2004, Internal medicine.

Combination therapy versus monotherapy for the treatment of patients with rheumatoid arthritis.

S. Pay, S. Kiraz, I. Ertenli, 1999, Clinical and experimental rheumatology.

Combination therapies in spondyloarthropathies.

S. Kiraz, I. Ertenli, V. Çobankara, 2004, The Kobe journal of medical sciences.

Massive Deep Venous Thrombosis and Venous Gangrene in a 29-year-old Case: Metastatic Epidermoid Carcinoma with an Unknown Primary

L. Coplu, I. Haznedaroglu, G. Karakaya, 2004, Hematology.

Infliximab, a TNF-alpha antagonist treatment in patients with ankylosing spondylitis: the impact on depression, anxiety and quality of life level

A. Akdoğan, U. Kalyoncu, O. Karadag, 2012, Rheumatology International.

Is visual loss due to giant cell arteritis reversible?

S. Pay, S. Kiraz, I. Ertenli, 2003, Yonsei medical journal.

Persistent Hypercalcemia Leading to Acute Pancreatitis in a Patient with Relapsed Myeloma and Renal Failure

E. Kansu, N. Güler, I. Barista, 1998, Nephron.